Construction of Fosmid-based SARS-CoV-2 replicons for antiviral drug screening and replication analyses in biosafety level 2 facilities

The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has necessitated the global development of countermeasures since its outbreak. However, current therapeutics and vaccines to stop the pandemic are insufficient and this is mainly...

Descripción completa

Detalles Bibliográficos
Autores principales: Takazawa, Shunta, Kotaki, Tomohiro, Nakamura, Satsuki, Utsubo, Chie, Kameoka, Masanori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374963/
https://www.ncbi.nlm.nih.gov/pubmed/37473963
http://dx.doi.org/10.1016/j.virusres.2023.199176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374963/
https://www.ncbi.nlm.nih.gov/pubmed/37473963
http://dx.doi.org/10.1016/j.virusres.2023.199176

Ejemplares similares